Hims & Hers Health Operating Income 2020-2024 | HIMS
Hims & Hers Health annual/quarterly operating income history and growth rate from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Hims & Hers Health operating income for the quarter ending December 31, 2024 was $0.019B, a 4749% decline year-over-year.
- Hims & Hers Health operating income for the twelve months ending December 31, 2024 was $0.062B, a 310.18% decline year-over-year.
- Hims & Hers Health annual operating income for 2024 was $0.062B, a 310.18% decline from 2023.
- Hims & Hers Health annual operating income for 2023 was $-0.029B, a 57.13% decline from 2022.
- Hims & Hers Health annual operating income for 2022 was $-0.069B, a 40.29% decline from 2021.
| Hims & Hers Health Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $62 |
| 2023 | $-29 |
| 2022 | $-69 |
| 2021 | $-115 |
| 2020 | $-15 |
| 2019 | $-74 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $19 |
| 2024-09-30 | $22 |
| 2024-06-30 | $11 |
| 2024-03-31 | $10 |
| 2023-12-31 | $0 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-9 |
| 2023-03-31 | $-11 |
| 2022-12-31 | $-12 |
| 2022-09-30 | $-20 |
| 2022-06-30 | $-20 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $-28 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-48 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-6 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.050B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |